IndraLab

Statements


Mutated ATXN3 inhibits MAP2. 1 / 1
| 1

reach
"Notably, mutant ataxin-3 triggered early synaptotoxicity (decreased synaptophysin and microtubule associated protein-2 staining) and reactive gliosis (glial fibrillary acidic protein and CD11b staining), which predated neuronal dysfunction and damage."